Search research articles
Contact Us
Filters
Showing results (151-160 of 353) with videos related to
Page
of 36
Sort By:
Blood Advances
|
January 23, 2023
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Danielle S Wallace, Clive S Zent, Andrea M Baran, et al.
Joint Commission Journal on Quality and Patient Safety
|
August 6, 2008
A controlled trial of a rapid response system in an academic medical center
Jeffrey M Rothschild, Seth Woolf, Kathleen M Finn, et al.
Leukemia & Lymphoma
|
October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
Makiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
Health Services Research
|
December 16, 2017
Pathways to Medical Home Recognition: A Qualitative Comparative Analysis of the PCMH Transformation Process
Peter Mendel, Emily K Chen, Harold D Green, et al.
Molecular Cancer Therapeutics
|
March 14, 2012
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
Tithi Biswas, Sughosh Dhakal, Rui Chen, et al.
Health Services Research
|
April 11, 2016
Advice to Quit Smoking and Ratings of Health Care among Medicare Beneficiaries Aged 65
Eleanor Winpenny, Marc N Elliott, Ann Haas, et al.
Blood
|
June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
Clinical Immunology (Orlando, Fla.)
|
January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
Paul M Barr, Chungwen Wei, James Roger, et al.
Bone Marrow Transplantation
|
September 18, 2003
Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma
J W Friedberg, H Kim, S Li, et al.
Page
of 36
Search research articles
Search
Showing results (151-160 of 353) with videos related to
Sort By:
Page
of 36
Blood Advances
|
January 23, 2023
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Danielle S Wallace, Clive S Zent, Andrea M Baran, et al.
Joint Commission Journal on Quality and Patient Safety
|
August 6, 2008
A controlled trial of a rapid response system in an academic medical center
Jeffrey M Rothschild, Seth Woolf, Kathleen M Finn, et al.
Leukemia & Lymphoma
|
October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
Makiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
Health Services Research
|
December 16, 2017
Pathways to Medical Home Recognition: A Qualitative Comparative Analysis of the PCMH Transformation Process
Peter Mendel, Emily K Chen, Harold D Green, et al.
Molecular Cancer Therapeutics
|
March 14, 2012
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
Tithi Biswas, Sughosh Dhakal, Rui Chen, et al.
Health Services Research
|
April 11, 2016
Advice to Quit Smoking and Ratings of Health Care among Medicare Beneficiaries Aged 65
Eleanor Winpenny, Marc N Elliott, Ann Haas, et al.
Blood
|
June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
Clinical Immunology (Orlando, Fla.)
|
January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
Paul M Barr, Chungwen Wei, James Roger, et al.
Bone Marrow Transplantation
|
September 18, 2003
Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma
J W Friedberg, H Kim, S Li, et al.
Page
of 36